TPI-1
CAS: 79756-69-7
Ref. 3D-EDA75669
| 1g | Discontinued | ||
| 2g | Discontinued | ||
| 5g | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
TPI-1
Description:
TPI-1 is a HDAC inhibitor that has shown to have an apoptotic effect on cancer cells. It inhibits the production of reactive oxygen species, leading to cell death. TPI-1 may inhibit gene transcription by binding to the protein phosphatase and inhibiting its activity. TPI-1 has been shown to have a primary tumor growth inhibitory effect in mouse models of breast cancer and cervical cancer. TPI-1 induces apoptosis in human cervical cancer cells. It also induces apoptosis in rat primary tumors implanted subcutaneously in athymic mice, with no observed toxicity.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
253.08 g/mol
Formula:
C12H6Cl2O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
